Navigation Links
Sinovac Reports Unaudited First Quarter 2011 Financial Results
Date:5/13/2011

2010.

The operating loss for the three months ended March 31, 2011 was $3.4 million, compared to $0.8 million for the same period of the prior year.  The increased operating loss in the first quarter of 2011 was primarily attributable to the higher cost of sales, increased administrative expenses from Sinovac Dalian and 100%-owned research and development Company, and higher R&D expenses.

Net loss for the first quarter of 2011 included $70,000 of interest and financing expenses, $154,000 of interest and other income, and $310,000 of income tax expenses. Net loss for the same period of 2010 included $124,000 of interest and financing income, $142,000 of interest and other income, and $269,000 of income tax recovery. Net loss attributable to shareholders for first quarter of 2011 was $2.8 million, or $0.05 per diluted share, as compared to $307,000, or $0.01 per diluted share, in the same period of 2010.

As of March 31, 2011, Sinovac's cash and cash equivalents totaled $91.0 million, compared to $101.6 million as of December 31, 2010.

Conference Call DetailsThe Company will host a conference call on Friday, May 13, 2011 at 8:00 a.m. EDT (May 13, 2011 at 8:00 pm China Standard Time) to review the Company's financial results for the first quarter ended March 31, 2011 and provide an update on recent corporate developments. To access the conference call, please dial 1-877-407-4018 (USA) or 1-201-689-8471 (international). A replay of the call will be available from 11 a.m. EDT on May 13, 2011 to May 27, 2011 at midnight. To access the replay, please dial 1-877-870-5176 (USA) or 1-858-384-5517 (international) and the replay pin number 371847.

A live audio webcast of the call will also be available from the Investors section on the corporate web site at http://www.sinovac.com . A webcast replay can be accessed on the corporate website beginning May 13, 2011 and the replay will remain avail
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sinovac Presents at Two Investor Conferences in May 2011
2. Sinovac Files Annual Report on Form 20-F
3. Sinovac Participates in UBS Greater China Healthcare Corporate Day
4. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
5. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
6. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
7. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
8. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
9. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
10. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
11. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, ... of over-the-counter (OTC) medicinal and healthcare products, announced it ... MigraPure® H, a hemp-based, advanced headache relief product, for ... in Colorado , Washington ... With the MigraPure H Advanced headache relief ...
(Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... patent infringement action against Chinese medical device manufacturer BMC Medical ... ruled today that BMC,s masks listed below infringe ResMed,s patents, ... selling these masks in the United States ... N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... Ohio , Dec. 23, 2014   ... treatment decision support to healthcare providers for behavioral ... it has secured $30 million in equity financing ... Virginia C. Drosos , President and Chief Executive ... clinical adoption and development of Assurex Health,s ...
Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... the need for more efficient and cost-effective bariatric surgical ... Endo-Surgery (EES), a global leader in surgical innovations, will ... innovative technologies during the American Society for Metabolic and ... Hotel and Convention Center in Orlando, Florida, June 12-17, ...
... Breckenridge Pharmaceutical, Inc. announced today ... granted final approval for the Company,s Abbreviated New ... of Activella® 0.5mg/0.1mg Tablets. The company currently markets ... Acetate 1.0mg/0.5mg) Tablets. Estradiol/Norethindrone Acetate Tablets ...
Cached Medicine Technology:Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 2Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 3Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 4Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 5Ethicon Endo-Surgery to Showcase Broadest Spectrum of Innovative Bariatric Surgical Options, Physician Best Practices and Mobile/Web-Based After-Care Patient Programs at ASMBS 6
(Date:12/25/2014)... FL (PRWEB) December 25, 2014 When head ... find themselves in a frenzy to get rid of it ... But families in Coral Gables now have the solution right ... second salon clinic location, Lice Troopers provides full spectrum head ... the Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut ...
(Date:12/25/2014)... -- The risk of burns from fires and cooking ... be extra cautious, an expert says. "Between Thanksgiving ... in patients coming in with burns," said Dr. Steven ... Burn Center of Stony Brook University Hospital in New ... but if not careful, could quickly turn tragic," Sandoval ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... be closing in on a "fountain of youth" drug that ... of older adults, a new study suggests. Seniors received ... drug that targets a genetic signaling pathway linked to aging ... The experimental medication, a version of the ...
(Date:12/25/2014)... 25, 2014 “ SmileStix ” was featured ... the latest and coolest mobile applications on the iOS, Android, ... host of NewsWatch, conducted the app review and shared with ... personal stickers. , The old saying goes, “A picture says ... words that can describe a single image, because each picture ...
(Date:12/25/2014)... Each year trauma accounts for approximately ... admissions across the nation (according to the Centers ... National Hospital Ambulatory Medical Care Survey collected data ... 2010. They estimated that there were between 3.5 and ... primary diagnosis of broken bone or fracture. , ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... new study led by Allison Kempe, MD, MPH, professor of ... director of the Children,s Outcomes Research (COR) Program at The ... primary care physicians who deliver vaccinations to children. Major findings ... concern about vaccines has either greatly or moderately increased in ...
... Institute on Drug Abuse (NIDA) announced today the launch ... education program designed to help primary care providers break ... program includes dramatic interpretation of a family,s struggle with ... foster compassion, cooperation, and understanding for patients living with ...
... Illicit drug overdose deaths in Vancouver,s Downtown Eastside dropped ... North America,s first supervised injection facility, according a new ... and the British Columbia Centre for Excellence in HIV/AIDS. ... study is the first to assess the impact of ...
... Missouri researchers believe both man and animal will benefit ... in Tibetan Terrier dogs can also be found in ... Fabiana Farias, a doctoral candidate in Area Genetics ... part of her thesis research. Gary Johnson, associate professor ...
... -- Rapid weight loss in the days before a wrestling ... a new study finds. U.S. researchers examined the physical ... Ten days before competing, the wrestlers were weighed and underwent ... amount of weight to lose before the match, using methods ...
... patients with high blood pressure and diabetes are at ... compared to otherwise healthy obese patients and patients of ... previous research demonstrating that obesity is associated with a ... and helps clarify the so-called "obesity paradox," or notion ...
Cached Medicine News:Health News:Results on national study of parental concerns about childhood vaccines announced 2Health News:Results on national study of parental concerns about childhood vaccines announced 3Health News:NIDA raises the curtain on addiction 2Health News:Overdose deaths down 35 percent after opening of Vancouver's supervised injection site: UBC-BC-CfE study 2Health News:Mutated gene found in dog disease the same in humans, MU researchers find 2Health News:Wrestlers' Quick Weight Loss May Cause Mental Confusion 2Health News:Obesity not always protective following surgery 2Health News:Obesity not always protective following surgery 3
... ZY is a low profile implantable ... for stimulation of either the atrium ... (straight model). All ZY leads are ... is used to extend/retract the fixation ...
The Vitatron Pirouet S+ lead series are endocardial leads with extendable/retractable helical screw designed for reliable fixation and optimal pacing characteristics....
Used with permanent pacing leads....
Implantable medical grade silicone end cap for insulation and sealing protection of 5 mm or 3.2 mm connectors....
Medicine Products: